University of California San Francisco

Chris E. Freise
Chris
Freise
MD, FACS

Professor of Surgery 
Chief, Division of Transplant Surgery

UCSF Diversity, Equity, and Inclusion Champion badge

Address

35 Medical Center Way, #001
San Francisco, CA 94143
United States

Email: [email protected]
Phone: 415-353-1898
Fax: 415-476-8709

Biography

Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

Education

Institution Degree Dept or School End Date
University of California Diversity, Equity, and Inclusion Champion Training 2019
University of California, San Francisco Transplant Fellowship School of Medicine 1995
University of California, San Francisco Post-Doc Fellow/Scholar School of Medicine 1991
University of Minnesota M.D. School of Medicine 1986

Board Certifications

  • American Board of Surgery, 1995

Clinical Expertise

Bile Duct Injuries
Bile Duct Strictures
Cholangiocarcinoma (Bile Duct Cancer)
Choledochal Cyst Disease
Dialysis Access
Expanded Criteria Donor Kidney Transplantation
Fulminant Hepatic Failure
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Intestinal Transplantation and Rehabilitation
Kidney and LIver Transplantation in HIV Patients
Kidney Auto-transplantation
Kidney Transplantation
Laparoscopic Donor Nephrectomy
Laparoscopic Kidney and Liver Surgery
Liver Transplantation
Living Donor Kidney Transplantation
Living Donor Liver Transplantation
Pancreas Transplantation
Pediatric Kidney Transplantation
Pediatric Liver Transplantation
Polycystic Kidney Disease
Polycystic Liver Disease
Portal Hypertension
Surgical Shunts

Grants and Funding

  • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients | NIH | 2002-09-01 - 2015-08-31 | Role: Principal Investigator

Research Narrative

Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

Research Interests

Delivery of Immunosuppressive Agents to Organ Allografts

Ischemia Reperfusion Injury

Improvement Organ Function in Deceased Donors

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 125
  1. Ureteral avulsion after ureteroscopy treated with renal auto-transplantation.
    Sanampudi R, Velasquez MC, Freise CE, Stoller ML| | PubMed
  2. Peritoneal Dialysis Catheter Complications after Insertion by Surgeons, Radiologists, or Nephrologists.
    Ku E, Copeland T, McCulloch CE, Freise C, Legaspi S, Weinhandl E, Woo K, Johansen KL| | PubMed
  3. DCD liver transplant in patients with a MELD over 35.
    Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| | PubMed
  4. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
    Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| | PubMed
  5. Motivations and outcomes of compatible living donor-recipient pairs in paired exchange.
    Chipman V, Cooper M, Thomas AG, Ronin M, Lee B, Flechner S, Leeser D, Segev DL, Mandelbrot DA, Lunow-Luke T, Syed S, Hil G, Freise CE, Waterman AD, Roll GR| | PubMed
  6. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
    Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL| | PubMed
  7. Biliary obstruction following ureteral revision of a transplanted kidney.
    Thiessen C, Arslan G, Roberts J, Freise C| | PubMed
  8. Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement".
    Wisel SA, Thiessen C, Day R, Belin LJ, Syed SM, Hirose R, Ascher N, Roberts JP, Freise CE| | PubMed
  9. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P| | PubMed
  10. Opioid use prior to liver transplant is associated with increased risk of death after transplant.
    Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL| | PubMed
125
View all 125 Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 125
  1. Ureteral avulsion after ureteroscopy treated with renal auto-transplantation.
    Sanampudi R, Velasquez MC, Freise CE, Stoller ML| | PubMed
  2. Peritoneal Dialysis Catheter Complications after Insertion by Surgeons, Radiologists, or Nephrologists.
    Ku E, Copeland T, McCulloch CE, Freise C, Legaspi S, Weinhandl E, Woo K, Johansen KL| | PubMed
  3. DCD liver transplant in patients with a MELD over 35.
    Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| | PubMed
  4. Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.
    Meier RPH, Kelly Y, Yamaguchi S, Braun HJ, Lunow-Luke T, Adelmann D, Niemann C, Maluf DG, Dietch ZC, Stock PG, Kang SM, Feng S, Posselt AM, Gardner JM, Syed SM, Hirose R, Freise CE, Ascher NL, Roberts JP, Roll GR| | PubMed
  5. Motivations and outcomes of compatible living donor-recipient pairs in paired exchange.
    Chipman V, Cooper M, Thomas AG, Ronin M, Lee B, Flechner S, Leeser D, Segev DL, Mandelbrot DA, Lunow-Luke T, Syed S, Hil G, Freise CE, Waterman AD, Roll GR| | PubMed
  6. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
    Braun HJ, Grab JD, Dodge JL, Syed SM, Roll GR, Schwab MP, Liu IH, Glencer AC, Freise CE, Roberts JP, Ascher NL| | PubMed
  7. Biliary obstruction following ureteral revision of a transplanted kidney.
    Thiessen C, Arslan G, Roberts J, Freise C| | PubMed
  8. Setting rules for the sandbox: A response to "Successfully sharing the sandbox: A perspective on combined DCD liver and heart donor procurement".
    Wisel SA, Thiessen C, Day R, Belin LJ, Syed SM, Hirose R, Ascher N, Roberts JP, Freise CE| | PubMed
  9. Treatment of immunocompromised COVID-19 patients with convalescent plasma.
    Fung M, Nambiar A, Pandey S, Aldrich JM, Teraoka J, Freise C, Roberts J, Chandran S, Hays SR, Bainbridge E, DeVoe C, Roque Gardner A, Yokoe D, Henrich TJ, Babik JM, Chin-Hong P| | PubMed
  10. Opioid use prior to liver transplant is associated with increased risk of death after transplant.
    Braun HJ, Schwab MP, Jin C, Amara D, Mehta NJ, Grace TR, Croci R, Freise CE, Roberts JP, Hirose R, Ascher NL| | PubMed
  11. Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients.
    Atreya CE, Collisson EA, Park M, Grenert JP, Behr SC, Gonzalez A, Chou J, Maisel S, Friedlander TW, Freise CE, Shoji J, Semrad TJ, Van Ziffle J, Chin-Hong P| | PubMed
  12. Contemporary Management of Hepatic Cyst Disease: Techniques and Outcomes at a Tertiary Hepatobiliary Center.
    Gomez A, Wisneski AD, Luu HY, Hirose K, Roberts JP, Hirose R, Freise CE, Nakakura EK, Corvera CU| | PubMed
  13. Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study.
    Meier RPH, Noguchi H, Kelly YM, Sarwal M, Conti G, Ward C, Halleluyan R, Tavakol M, Stock PG, Freise CE| | PubMed
  14. Inferior Long-Term Graft Survival of Suboptimal Kidneys After Living Donor Kidney Transplantation.
    Yamanaga S, Freise CE, Stock PG, Rosario A, Fernandez D, Kobayashi T, Tavakol M, Kang SM| | PubMed
  15. Rapid Modification of Workflows and Fellow Staffing at a Single Transplant Center to Address the COVID-19 Crisis.
    Thiessen C, Wisel SA, Yamaguchi S, Dietch ZC, Feng S, Freise CE| | PubMed
  16. Living Donor Liver Transplant for Alcoholic Liver Disease: Data from the Adult-to-adult Living Donor Liver Transplantation Study.
    Braun HJ, Dodge JL, Grab JD, Syed SM, Roll GR, Freise CE, Roberts JP, Ascher NL| | PubMed
  17. Bi-organ paired exchange-Sentinel case of a liver-kidney swap.
    Torres AM, Wong F, Pearson S, Weinberg S, Roberts JP, Ascher NL, Freise CE, Lee BK| | PubMed
  18. Fatigue, Pain, and Other Physical Symptoms of Living Liver Donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study.
    Butt Z, DiMartini AF, Liu Q, Simpson MA, Smith AR, Zee J, Gillespie BW, Holtzman S, Ladner D, Olthoff K, Fisher RA, Hafliger S, Freise CE, Mandell MS, Sherker AH, Dew MA| | PubMed
  19. Splenic Vein Thrombosis Following Pancreas Transplantation: Identification of Factors That Support Conservative Management.
    Harbell JW, Morgan T, Feldstein VA, Roll GR, Posselt A, Kang SM, Feng S, Hirose R, Freise CE, Stock P| | PubMed
  20. Collagen XIV and a related recombinant fragment protect human vascular smooth muscle cells from calcium-/phosphate-induced osteochondrocytic transdifferentiation.
    Freise C, Bobb V, Querfeld U| | PubMed
  21. Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.
    Wisel SA, Gardner JM, Roll GR, Harbell J, Freise CE, Feng S, Kang SM, Hirose R, Kaufman DB, Posselt AM, Stock PG| | PubMed
  22. Vascular complication rates in living donor liver transplantation: How low can we go?
    Freise CE| | PubMed
  23. A Single Perioperative Injection of Dexamethasone Decreases Nausea, Vomiting, and Pain after Laparoscopic Donor Nephrectomy.
    Yamanaga S, Posselt AM, Freise CE, Kobayashi T, Tavakol M, Kang SM| | PubMed
  24. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature.
    Kluijfhout WP, Drake FT, Pasternak JD, Beninato T, Mitmaker EJ, Gosnell JE, Shen WT, Suh I, Freise CE, Duh QY| | PubMed
  25. Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2).
    DiMartini A, Dew MA, Liu Q, Simpson MA, Ladner DP, Smith AR, Zee J, Abbey S, Gillespie BW, Weinrieb R, Mandell MS, Fisher RA, Emond JC, Freise CE, Sherker AH, Butt Z| | PubMed
  26. Early Postoperative Pain and its Predictors in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Mandell MS, Smith AR, Dew MA, Gordon DB, Holtzman S, Howell T, DiMartini AF, Butt Z, Simpson MA, Ladner DP, Freise CE, McCluskey SA, Fisher RA, Guarrera JV, Olthoff KM, Pomfret EA| | PubMed
  27. Impact of Graft Selection on Donor and Recipient Outcomes After Living Donor Liver Transplantation.
    Braun HJ, Dodge JL, Roll GR, Freise CE, Ascher NL, Roberts JP| | PubMed
  28. Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.
    Dew MA, DiMartini AF, Ladner DP, Simpson MA, Pomfret EA, Gillespie BW, Merion RM, Zee J, Smith AR, Holtzman S, Sherker AH, Weinrieb R, Fisher RA, Emond JC, Freise CE, Burton JR, Butt Z| | PubMed
  29. Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.
    Samstein B, Smith AR, Freise CE, Zimmerman MA, Baker T, Olthoff KM, Fisher RA, Merion RM| | PubMed
  30. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A| | PubMed
  31. Laparoscopic Nephrectomy with Autotransplantation: Safety, Efficacy and Long-Term Durability.
    Tran G, Ramaswamy K, Chi T, Meng M, Freise C, Stoller ML| | PubMed
  32. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.
    Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, Freise CE, Gillespie BW, Everhart JE| | PubMed
  33. Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).
    Ladner DP, Dew MA, Forney S, Gillespie BW, Brown RS, Merion RM, Freise CE, Hayashi PH, Hong JC, Ashworth A, Berg CL, Burton JR, Shaked A, Butt Z| | PubMed
  34. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
    Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA| | PubMed
  35. Emesis following laparoscopic left donor nephrectomy.
    Luu HY, Ulloa JG, Roll GR, Freise CE| | PubMed
  36. Ex vivo split-liver transplantation: the true right/left split.
    Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| | PubMed
  37. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS, A2ALL Study Group| | PubMed
  38. Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma.
    Park SJ, Freise CE, Hirose R, Kerlan RK, Yao FY, Roberts JP, Vagefi PA| | PubMed
  39. Complications of living donor hepatic lobectomy--a comprehensive report.
    Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM, A2ALL Study Group| | PubMed
  40. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.
    Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP| | PubMed
  41. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010.
    Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE| | PubMed
  42. Liver transplantation for giant hepatic angiomyolipoma.
    Vagefi PA, Eilers H, Hiniker A, Freise CE| | PubMed
  43. Experience with laparoscopic donor nephrectomy among more than 1000 cases: low complication rates, despite more challenging cases.
    Ahearn AJ, Posselt AM, Kang SM, Roberts JP, Freise CE| | PubMed
  44. Ten-year retrospective analysis of incisional herniorrhaphy following renal transplantation.
    Chang EI, Galvez MG, Padilla BE, Freise CE, Foster RD, Hoffman WY| | PubMed
  45. Fibrin plug.
    Vagefi PA, Freise CE| | PubMed
  46. Outcomes of surgical repair of bile leaks and strictures after adult-to-adult living donor liver transplant.
    Melcher ML, Freise CE, Ascher NL, Roberts JP| | PubMed
  47. Comparison of biliary complications in adult living-donor liver transplants performed at two busy transplant centers.
    Melcher ML, Pomposelli JJ, Verbesey JE, McTaggart RA, Freise CE, Ascher NL, Roberts JP, Pomfret EA| | PubMed
  48. Inguinal herniation of a transplant ureter.
    Odisho AY, Freise CE, Tomlanovich SJ, Vagefi PA| | PubMed
  49. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review.
    Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM| | PubMed
  50. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome.
    Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP| | PubMed
  51. Open incisional hernia repair at an academic tertiary care medical center.
    Mohebali K, Young DM, Hansen SL, Shawo A, Freise CE, Chang DS, Maa J, Harris HW| | PubMed
  52. Prostate cancer screening and treatment in the transplant population: current status and recommendations.
    Breyer BN, Whitson JM, Freise CE, Meng MV| | PubMed
  53. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, Fisher R| | PubMed
  54. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.
    Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE, A2ALL Study Group| | PubMed
  55. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.
    Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP| | PubMed
  56. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study.
    Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF, Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group| | PubMed
  57. Donor morbidity after living donation for liver transplantation.
    Ghobrial RM, Freise CE, Trotter JF, Tong L, Ojo AO, Fair JH, Fisher RA, Emond JC, Koffron AJ, Pruett TL, Olthoff KM, A2ALL Study Group| | PubMed
  58. Organ donation and utilization in the United States, 1997-2006.
    Sung RS, Galloway J, Tuttle-Newhall JE, Mone T, Laeng R, Freise CE, Rao PS| | PubMed
  59. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
    Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, Freise CE, Benet LZ, Ascher NL, Roberts JP, Murphy B, Keller MJ, Olthoff KM, Blumberg EA, Brayman KL, Bartlett ST, Davis CE, McCune JM, Bredt BM, Stablein DM, Stock PG| | PubMed
  60. Long-term outcomes and late complications of laparoscopic nephrectomy with renal autotransplantation.
    Eisenberg ML, Lee KL, Zumrutbas AE, Meng MV, Freise CE, Stoller ML| | PubMed
  61. Catheter-directed therapy for DVT after pancreas transplantation.
    Mahanty HD, Posselt AM, Lipshutz GS, Schneider DB, Freise CE| | PubMed
  62. Laparoscopic nephrectomy, ex vivo partial nephrectomy followed by allograft renal transplantation.
    Whitson JM, Stackhouse GB, Freise CE, Meng MV, Stoller ML| | PubMed
  63. Improvement in survival associated with adult-to-adult living donor liver transplantation.
    Berg CL, Gillespie BW, Merion RM, Brown RS, Abecassis MM, Trotter JF, Fisher RA, Freise CE, Ghobrial RM, Shaked A, Fair JH, Everhart JE, A2ALL Study Group| | PubMed
  64. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
    Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL, A2ALL Study Group| | PubMed
  65. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury.
    Fuller TF, Rose F, Singleton KD, Linde Y, Hoff U, Freise CE, Dragun D, Niemann CU| | PubMed
  66. Predicting biliary complications in right lobe liver transplant recipients according to distance between donor's bile duct and corresponding hepatic artery.
    Yeh BM, Coakley FV, Westphalen AC, Joe BN, Freise CE, Qayyum A, McTaggart RA, Roberts JP| | PubMed
  67. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
    Fuller TF, Hoff U, Rose F, Linde Y, Freise CE, Dragun D, Feng S| | PubMed
  68. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP| | PubMed
  69. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation.
    Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE| | PubMed
  70. More than 500 consecutive laparoscopic donor nephrectomies without conversion or repeated surgery.
    Melcher ML, Carter JT, Posselt A, Duh QY, Stoller M, Freise CE, Kang SM| | PubMed
  71. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.
    Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, Hulbert-Shearon TE, Gillespie BW, Emond JC, A2ALL Study Group| | PubMed
  72. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient.
    Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM| | PubMed
  73. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants.
    Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU| | PubMed
  74. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Posselt AM, Freise CE| | PubMed
  75. Laparoscopic right donor nephrectomy: a large single-center experience.
    Posselt AM, Mahanty H, Kang SM, Stoller ML, Meng MV, Roberts JP, Freise CE| | PubMed
  76. Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival.
    Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE| | PubMed
  77. Laparoscopic nephrectomy, ex vivo excision and autotransplantation for complex renal tumors.
    Meng MV, Freise CE, Stoller ML| | PubMed
  78. Early graft function after living donor kidney transplantation predicts rejection but not outcomes.
    Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S| | PubMed
  79. Laparoscopic-assisted upper pole ureterocalicostomy using renal inversion and autotransplantation.
    Greene KL, Meng MV, Abrahams HM, Freise CE, Stoller ML| | PubMed
  80. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P| | PubMed
  81. Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience.
    Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Freise CE| | PubMed
  82. Technique, indications and outcomes of pure laparoscopic right donor nephrectomy.
    Abrahams HM, Freise CE, Kang SM, Stoller ML, Meng MV| | PubMed
  83. Pure laparoscopic right donor nephrectomy: step-by-step approach.
    Abrahams HM, Meng MV, Freise CE, Stoller ML| | PubMed
  84. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts.
    Fuller TF, Serkova N, Niemann CU, Freise CE| | PubMed
  85. Laparoscopic donor nephrectomy for pediatric recipients: outcomes analysis.
    Abrahams HM, Meng MV, Freise CE, Stoller ML| | PubMed
  86. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury.
    Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S| | PubMed
  87. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.
    Freise CE, Kang SM, Feng S, Hirose R, Stock P| | PubMed
  88. Laparoscopic radical nephrectomy for suspected renal cell carcinoma in dialysis-dependent patients.
    Gulati M, Meng MV, Freise CE, Stoller ML| | PubMed
  89. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL| | PubMed
  90. Management of lymphoceles after renal transplantation: laparoscopic versus open drainage.
    Fuller TF, Kang SM, Hirose R, Feng S, Stock PG, Freise CE| | PubMed
  91. Sclerosing peritonitis.
    Meng MV, Freise CE, Stoller ML| | PubMed
  92. Expanded experience with laparoscopic nephrectomy and autotransplantation for severe ureteral injury.
    Meng MV, Freise CE, Stoller ML| | PubMed
  93. Techniques to optimize vascular control during laparoscopic donor nephrectomy.
    Meng MV, Freise CE, Kang SM, Duh QY, Stoller ML| | PubMed
  94. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice.
    Corbascio M, Mahanty H, Osterholm C, Qi Z, Pearson TC, Larsen CP, Freise CE, Ekberg H| | PubMed
  95. Successful long-term outcomes using pediatric en bloc kidneys for transplantation.
    Hiramoto JS, Freise CE, Randall HR, Bretan PN, Tomlanovich S, Stock PG, Hirose R| | PubMed
  96. Laparoscopic nephrectomy and autotransplantation for severe iatrogenic ureteral injuries.
    Shekarriz B, Lu H, Duh Q, Freise CE, Stoller ML| | PubMed
  97. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
    Chang GJ, Mahanty HD, Vincenti F, Freise CE, Roberts JP, Ascher NL, Stock PG, Hirose R| | PubMed
  98. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated.
    Chang GJ, Mahanty HD, Quan D, Freise CE, Ascher NL, Roberts JP, Stock PG, Hirose R| | PubMed
  99. Prolonged cold ischemia time obviates the benefits of 0 HLA mismatches in renal transplantation.
    Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE| | PubMed
  100. The effect of age and prolonged cold ischemia times on the national allocation of cadaveric renal allografts.
    Lee CM, Carter JT, Randall HB, Hiose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey EJ| | PubMed
  101. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
    O'Rourke RW, Osorio RW, Freise CE, Lou CD, Garovoy MR, Bacchetti P, Ascher NL, Melzer JS, Roberts JP, Stock PG| | PubMed
  102. Liver transplantation for autoimmune hepatitis: rejection and recurrence.
    Narumi S, Hakamada K, Sasaki M, Freise CE, Stock PG, Roberts JP, Ascher NL| | PubMed
  103. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma.
    Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP| | PubMed
  104. Simultaneous pancreas-kidney transplantation: an overview of indications, complications, and outcomes.
    Freise CE, Narumi S, Stock PG, Melzer JS| | PubMed
  105. Hepatic artery pseudoaneurysm with hemobilia following angioplasty after liver transplantation.
    Narumi S, Osorio RW, Freise CE, Stock PG, Roberts JP, Ascher NL| | PubMed
  106. Risks associated with conversion of stable patients after liver transplantation to the microemulsion formulation of cyclosporine.
    Freise CE, Galbraith CA, Nikolai BJ, Ascher NL, Lake JR, Stock PG, Roberts JP| | PubMed
  107. Increased morbidity and mortality of simultaneous pancreas-renal transplantation in patients over 49 years of age.
    Freise CE, Stock PG, Melzer JS| | PubMed
  108. Liver transplantation improves survival of rats bearing hepatoma-3924A.
    Roberts JP, Liu T, Freise CE, Mielczarek J, Ferrell L, Randall H, Ascher NL| | PubMed
  109. Hepatotoxins and liver transplantation decrease pulmonary metastases in rats with hepatoma.
    Freise CE, Liu T, Ascher NL, Roberts JP| | PubMed
  110. Low postoperative wound infection rates are possible following simultaneous pancreas-kidney transplantation.
    Freise CE, Stock PG, Roberts JP, Melzer JS| | PubMed
  111. Increased efficacy of CSA following rearterialization in the rat OLTX model.
    Freise CE, Liu T, Osorio RW, Ferrell L, Ascher NL, Roberts JP| | PubMed
  112. The increased efficacy and decreased nephrotoxicity of a cyclosporine liposome.
    Freise CE, Liu T, Hong K, Osorio RW, Papahadjopoulos D, Ferrell L, Ascher NL, Roberts JP| | PubMed
  113. Major histocompatibility complex class I deficiency prolongs islet allograft survival.
    Osorio RW, Ascher NL, Jaenisch R, Freise CE, Roberts JP, Stock PG| | PubMed
  114. Nonoperative management of biliary leaks after orthotopic liver transplantation.
    Osorio RW, Freise CE, Stock PG, Lake JR, Laberge JM, Gordon RL, Ring EJ, Ascher NL, Roberts JP| | PubMed
  115. Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
    Freise CE, Hebert M, Osorio RW, Nikolai B, Lake JR, Kauffman RS, Ascher NL, Roberts JP| | PubMed
  116. Isolation of functional MHC class I-deficient islet cells.
    Osorio RW, Ascher NL, Jaenisch R, Natuzzi ES, Freise CE, Roberts JP, Stock PG| | PubMed
  117. Orthotopic liver transplantation for end-stage alcoholic liver disease.
    Osorio RW, Freise CE, Ascher NL, Roberts JP, Avery M, Lake JR| | PubMed
  118. Acute liver rejection: evaluation with cell-directed MR contrast agents in a rat transplantation model.
    Mühler A, Freise CE, Kuwatsuru R, Rosenau W, Liu T, Mintorovitch J, Clement O, Vexler V, Mahboubi S, Lang P| | PubMed
  119. A modified vascular "sleeve" anastomosis for rearterialization in orthotopic liver transplantation in rats.
    Liu T, Freise CE, Ferrell L, Ascher NL, Roberts JP| | PubMed
  120. Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.
    Freise CE, Rowley H, Lake J, Hebert M, Ascher NL, Roberts JP| | PubMed
  121. Wound healing after anorectal surgery in human immunodeficiency virus-infected patients.
    Burke EC, Orloff SL, Freise CE, Macho JR, Schecter WP| | PubMed
  122. Demonstration of local immunosuppression with methylprednisolone in the sponge matrix allograft model.
    Freise CE, Clemmings S, Clemens LE, Alan T, Ashby T, Ashby E, Burke EC, Roberts JP, Ascher NL| | PubMed
  123. Characterization of a cyclosporine-containing liposome.
    Freise CE, Hong K, Clemens LE, Papahadjopoulos D, Burke E, Martinez O, Lake J, Ascher NL, Roberts JP| | PubMed
  124. Comparison of three regimens for cytomegalovirus prophylaxis in 147 liver transplant recipients.
    Freise CE, Pons V, Lake J, Burke E, Ascher NL, Roberts JP| | PubMed
  125. MHC expression on human hepatocytes before and after isolation.
    Burke EC, Martinez OM, Freise CE, McVicar J, Roberts JP, Ascher NL| | PubMed